US Patent 9938267 Heterocyclic inhibitors of glutaminase
Patent 9938267 was granted and assigned to Calithera Biosciences on April, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9938267 Heterocyclic inhibitors of glutaminase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.